drugset
drugset / Trial / NCT02860897

Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery

NCT02860897 ↗

Phase 4 Withdrawn University Hospitals Cleveland Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

PURPOSE: To evaluate patient adherence to cream versus tablet based local estrogen therapy by randomizing treatment modalities to determine differences in adherence to either form. HYPOTHESIS: There is no difference in adherence to cream versus tablet based local estrogen therapy when prescribed as a 6 week course of postoperative therapy after female pelvic reconstructive surgery.

Timeline

Start
2016-07
Primary completion
2017-04
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified — Other
Subject conjugated estrogens Other / unclassified — Other

Indications

No indication recorded.